Evidence map›Paper›PMID 42315714›Full record

ArticleMetabolomics : Official journal of the Metabolomic Society2026

Lipidomics of longer-term effects in the murine model after exposure to mixed field radiation and combined infection.

Evan L Pannkuk, Anika Kot, Lorreta Yun-Tien Lin, Raymond Song, Shivani Bansal, Meth M Jayatilake, Andrew D Harken, Naresh T Deoli, Brian Ponnaiya, Guy Garty and 2 more

Abstract read
In one paragraph

Article in Metabolomics : Official journal of the Metabolomic Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Evan L PannkukDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA. elp44@georgetown.edu.
Anika KotDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
Lorreta Yun-Tien LinDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
Raymond SongSchool of Health, Georgetown University, Washington, DC, USA.
Shivani BansalDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
Meth M JayatilakeDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
Andrew D HarkenCenter for Radiological Research, Columbia University Irving Medical Center, New York, NY, USA.
Naresh T DeoliCenter for Radiological Research, Columbia University Irving Medical Center, New York, NY, USA.
Brian PonnaiyaCenter for Radiological Research, Columbia University Irving Medical Center, New York, NY, USA.
Guy GartyCenter for Radiological Research, Columbia University Irving Medical Center, New York, NY, USA.
Albert J FornaceDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
Heng-Hong LiDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA. hl234@georgetown.edu.

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI MARCUS S NOEL · 1990 to 2026
$71.5M
Metabolic impairment plays a critical role in radiation-induced T cell immune dysfunctionU01AI170024 · NIAID · GEORGETOWN UNIVERSITY · PI Albert J Fornace · 2022 to 2026
$3.4M
Development of a multiomic biodosimetry panel for use during sepsis and antibiotic treatmentR21AI193957 · NIAID · GEORGETOWN UNIVERSITY · PI Evan Pannkuk · 2025 to 2026
$312k
National Institutes of Health (National Institute of Allergy and Infectious Diseases 1R21AI193957National Institutes of Health (National Institute of Allergy and Infectious Diseases 5U01AI170024NCI NIH HHS P30 CA051008NIAID NIH HHS R21 AI193957NIAID NIH HHS U01 AI170024
6 · The paper itself

Abstract

backgroundAccurate biodosimetry is essential for medical response during nuclear emergencies. However, mixed-field radiation and secondary infections create significant diagnostic challenges.

objectiveThis study aimed to characterize persistent serum lipidomic alterations following mixed-field exposures at long-term time points and evaluate the impact of a delayed secondary infection on radiation-associated signatures to determine the feasibility of serum biomarkers for complex biodosimetry.

methodsTarget serum lipidomics and untargeted metabolomics were performed on male C57BL/6 mice 6 weeks after a 3 Gy total body irradiation (TBI) with X rays or mixed γ-ray/neutron fields (5%-80% neutron fractions). A subset modeled secondary complications via a delayed Listeria monocytogenes (Lm-OVA) infection at 5 weeks post-TBI.

resultsMixed-field exposures produced significant, quality-dependent reductions in mitochondrial cardiolipins (CL) and ether-linked phosphatidylethanolamines (ePEs) compared to sham or X ray groups. Untargeted analysis identified that Lm-OVA infection introduced massive systemic metabolic variation. Targeted profiling revealed that while infection alone significantly reduced ceramide and hexosylceramide levels, irradiated and infected mice exhibited profiles resembling irradiated-only animals, suggesting radiation-induced immune suppression attenuates infection-driven lipid remodeling.

conclusionRadiation quality drives distinct, long-term serum lipidomic signatures that post-exposure infection modulates but does not override. These findings support the advancement of circulating lipids as mechanistically informative biomarkers and the feasibility of serum lipidomics for multiplex biomarker panels in emergency preparedness.

Indexed as

LipidomicsLipidsAnimalsBiomarkersDisease Models, AnimalGamma RaysListeria monocytogenesMaleMetabolomicsMiceMice, Inbred C57BLWhole-Body IrradiationBiomarkersLipids

Identifiers

PMID42315714
PMCPMC13279580

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.